GlassScriptPhysician profile
Natalie Roodbeen
NPI 1114641412
$807.80
in general payments reported to CMS, 2019-2025
16 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.74 · 2023: $115 · 2024: $399 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $196.28 | 2022-2024 | Jornay Pm |
| Pfizer INC. | $116.94 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $73.06 | 2024-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Alexion Pharmaceuticals, INC. | $65.66 | 2022-2024 | Strensiq |
| Supernus Pharmaceuticals, INC. | $56.31 | 2024-2025 | Qelbree |
| Corium, LLC | $45.20 | 2023 | Azstarys |
| Cipher Pharmaceuticals US LLC | $38.05 | 2025 | Spinosad, Natroba |
| Sanofi Pasteur INC. | $34.66 | 2023-2024 | |
| Neurelis, INC. | $33.74 | 2023-2025 | Valtoco |
| Collegium Pharmaceutical, INC. | $33.01 | 2025 | Jornay Pm |
| Tris Pharma INC | $29.15 | 2025 | Onyda Xr |
| Tempus Ai, INC | $22.67 | 2024 | |
| Biomerieux INC | $20.82 | 2025 | Biofire Spotfire Control Station |
| Phadia US INC. | $14.88 | 2025 | Immunocap |
| Seqirus USA INC | $14.26 | 2025 | Flucelvax |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $13.11 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Roodbeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.